Inbio Achieves Double-Digit Growth in First-Half Sales and Operating Profit

Inbio recorded sales of KRW 24.59 billion in the first half of the year, up 10.0% from the same period last year, and operating profit of KRW 3.3 billion, an increase of 10.5% compared to the previous year.

According to Inbio on August 13, sales to NongHyup in the first half surged by 71% compared to the same period last year, achieving double-digit growth. Through active sales efforts, the company is targeting NongHyup sales of more than KRW 12 billion this year.

By product, overseas sales expansion was particularly notable for herbicides and fungicides. In the first half, exports of herbicides and fungicides rose by 567% and 153%, respectively, compared to the previous year, marking a significant increase. Domestic sales of both products also grew by 17%, continuing a steady growth trend.

Further improvement in performance is anticipated in the second half of the year. Inbio plans to broaden its product portfolio by developing new product categories, including fungicides, insecticides, and herbicides. This strategy is aimed at building a new revenue base.

A representative from Inbio stated, "In the first half, our business foundation expanded across major sales channels, enabling us to achieve both topline growth and improved profitability," adding, "In the second half, we will focus on maintaining stable sales growth for our existing business while securing mid- to long-term growth momentum through expansion of new product categories and joint development of new substances."

This content was produced with the assistance of AI translation services.